Excellent result of FluoGuide’s FG001 guiding surgical removal of cancer is published
FluoGuide A/S’s ("FluoGuide") compound FG001 lights up the cancer and its invasive growth and has demonstrated potential to vastly improve the radicality of surgery in preclinical studies. FluoGuide can announce that data which confirms FG001’s potential in guiding surgical removal of pancreatic cancer has now also been published in peer reviewed journal.The study aimed at investigating the resection of the human pancreatic cancer using an orthotopic xenograft pancreatic cancer model and also to investigate if fluorescent-guided imaging could locate additional metastases after conventional